Actionable news
All posts from Actionable news
Actionable news in CELG: Celgene Corporation,

Celgene's Revlimid approved in Europe for mantle cell lymphoma

The European Commission approves Celgene's (NASDAQ:CELG) top seller Revlimid (lenalidomide) for relapsed/refractory mantle cell lymphoma, a rare subtype of non-Hodgkin's lymphoma that is very resistant to treatment. Fewer than half of sufferers survive longer...